Zygmont Chester Stanley III 4
4 · REVELATION BIOSCIENCES, INC. · Filed Oct 31, 2025
Insider Transaction Report
Form 4
Zygmont Chester Stanley III
Chief Financial Officer
Transactions
- Award
Common Stock
2025-10-29$1.28/sh+390,614$499,986→ 395,645 total(indirect: By Trust)
Holdings
- 5(indirect: By LLC)
Common Stock
- 5,026(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests quarterly over one year from the date of grant.
- [F2]Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.
- [F3]Shares are held by Czeslaw Capital Fund, LLC. Chester S Zygmont III is the sole manager of Czeslaw Capital Fund, LLC.